This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Recurrent miscarriage: diabetes drug could ... An existing drug can be used to improve the womb for pregnancy, ... (08 Jan 2020)
Nerve Stimulation May Benefit Women with ... A treatment involving electrical nerve stimulation helped women ... (08 Jan 2020)
Cancer drugs could potentially treat COPD, ... New research from the University of Sheffield shows a certain ... (08 Jan 2020)
Tea drinkers live longer Drinking tea at least three times a week is linked with a longer ... (08 Jan 2020)
How diet affects mental health – what’s the ... A new expert review confirms that diet significantly influences ... (08 Jan 2020)
×

Warning

JUser: :_load: Unable to load user with ID: 5232
Wednesday, 09 October 2019 19:38

Study Provides Insights on Statins’ Link to Lower Prostate Cancer Risk Featured

Rate this item
(0 votes)

In a study of cancer‐free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer.

In the Cancer Medicine study, this association was observed only when statins had been used for a relatively long duration or at a high dose, and it was more pronounced for aggressive prostate tumors.
Among 13,065 men in the study, 2,976 were diagnosed with prostate cancer over a follow-up of up to 22 years.

“More strictly designed clinical trial studies are needed to replicate this finding,” said Kai Wang, first author, PhD, of Harvard University.



Source: Wiley

Full bibliographic information

Wang, K, Gerke, TA, Chen, X, Prosperi, M. Association of statin use with risk of Gleason score‐specific prostate cancer: A hospital‐based cohort study. Cancer Medicine. 2019; 00: 1– 9. .

Read 323 times

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…